Patients
Bringing parity to infertility, with Jean Duvall
During JPM2026, pharmaphorum spoke with Jean Duvall, CEO of Repronovo, a company that’s working on new infertility treatments for men and women.
Sales & Marketing
Rewiring commercialisation to meet the moment, with Helen Sa...
At the Informa Biotech Showcase at JPM2026, EVERSANA President Greg Skalicky and Helen Sabzevari, CEO of Precigen, discuss new commercialisation.
Oncology
Unlocking the future of epigenetics, with Carlos Buesa
Carlos Buesa, CEO of Oryzon Genomics, discusses exploring how epigenetics is reshaping the landscape of oncology and CNS therapies.
R&D
Is this the year for precision psychology? With Amit Etkin
At the Sachs Neuroscience Forum just before the start of JPM 2026 in San Francisco, pharmaphorum spoke with Amit Etkin, CEO of Alto Neuroscience.
Digital
Cracking the code: How European biotechs can win in the US m...
At Frontiers Health 2025, Mike Ryan, General Manager Europe at EVERSANA, tackled one of the most pressing questions for emerging pharma and biotech...
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
